Meta-analyses show statistically significant but clinically modest reductions in body weight with L-carnitine supplementation, particularly in older adults and those with obesity or metabolic conditions
TB-500 is a synthetic version of thymosin beta-4 and is often examined alongside growth factors and actin-related processes
Nagasawa's work assumes even greater significance as the impact of oxidative stress on various health conditions becomes increasingly evident
Fetal IGF-1 concentrations increased in animals that received oIGF-1 infusion for 1 week (Figure 5A)
DOSE-RESPONSE CURVES IN THE ESTIMATION OF POTENCY OF LIPOTROPIC AGENTS*
Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial